文献速递美容整形

氨甲环酸对面部美容手术术后并发症及出血影响的系统综述与Meta分析

Impact of tranexamic acid on postoperative complications and bleeding in facial aesthetic surgery: A systematic review and meta-analysis.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2025-05-20

该系统综述与Meta分析纳入2004至2024年间22项研究共9005例患者,评估氨甲环酸在面部美容手术(如鼻整形、除皱术、眼睑成形术)中的作用。结果显示氨甲环酸显著减少失血量、术后水肿和瘀斑,平均手术时间122.17(SD: 34.44)分钟,平均失血量86.63(SD: 56.93)cc,并持续降低引流量和术后并发症。

要点

  • 氨甲环酸显著减少面部美容手术的失血量、术后水肿和瘀斑。
  • 氨甲环酸持续降低引流量和术后并发症,尤其在鼻整形和除皱术中。
  • 静脉、局部或浸润等给药途径未显示显著全身并发症。

核心结论

  • 氨甲环酸是面部美容手术的有效辅助手段,可减少术中出血、手术时间及水肿和瘀斑等术后后遗症,并显示安全性和有效性。

研究设计与样本

  • 本系统综述遵循PRISMA指南,综合2004至2024年间发表的随机对照试验、队列研究和病例对照研究,检索PubMed、Embase、Cochrane Library和Google Scholar数据库,纳入22项研究共9005例患者。

主要发现

  • 氨甲环酸显著减少失血量、术后水肿和瘀斑。
  • 平均手术时间为122.17(SD: 34.44)分钟,平均失血量为86.63(SD: 56.93)cc。
  • 氨甲环酸持续降低引流量和术后并发症,尤其在鼻整形和除皱术中。
  • 静脉、局部或浸润等不同给药途径未显示显著全身并发症。
  • 氨甲环酸与局部麻醉药联用可改善止血和麻醉效果。

临床怎么用

  • 氨甲环酸可作为面部美容手术的有效辅助手段,以减少术中出血、手术时间及术后水肿和瘀斑。
  • 氨甲环酸在鼻整形和除皱术中持续降低引流量和术后并发症。
  • 静脉、局部或浸润给药途径未显示显著全身并发症,与局部麻醉药联用可改善止血和麻醉效果。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tranexamic acid (TXA) is a synthetic antifibrinolytic agent originally developed for hemostasis, which is now widely used in aesthetic and reconstructive surgery. Its application in facial cosmetic procedures is aimed at reducing bleeding, swelling, and bruising. This systematic review assesses the impact of TXA on postoperative outcomes in facial cosmetic surgery, focusing on blood loss, surgical time, edema, and ecchymosis. METHODS: This review followed the preferred reporting items for systematic reviews and meta-analyses guidelines and synthesized data from randomized controlled trials, cohort studies, and case-control studies published between 2004 and 2024. Eligible studies examined TXA in aesthetic facial surgeries (e.g., rhinoplasty, rhytidectomy, and blepharoplasty). Outcomes included intraoperative bleeding, surgical time, postoperative edema, ecchymosis, and patient satisfaction. A comprehensive search was conducted across the PubMed, Embase, Cochrane Library, and Google Scholar databases. RESULTS: Twenty-two studies involving 9005 patients were included. TXA significantly reduced blood loss, postoperative edema, and ecchymosis. The average surgical time was 122.17 (SD: 34.44) min, with mean blood loss of 86.63 (SD: 56.93) cc. TXA use consistently decreased drain output and postoperative complications, particularly in rhinoplasty and rhytidectomy. Various administration routes (intravenous, topical, or local infiltration) showed no significant systemic complications. Combining TXA with local anesthetics improved hemostatic and anesthetic efficacy. CONCLUSION: TXA is an effective adjunct in facial cosmetic surgery that reduces intraoperative bleeding, surgical time, and postoperative sequelae such as edema and ecchymosis. Further studies are needed to establish standardized dosing and objective outcome grading. TXA demonstrated safety and efficacy indicating that it should become a standard practice in facial aesthetic procedures.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Prabhughate A, Bellani D, Shome D, et al. Impact of tranexamic acid on postoperative complications and bleeding in facial aesthetic surgery: A systematic review and meta-analysis. J Plast Reconstr Aesthet Surg. 2025. PMID: 40449323. doi:10.1016/j.bjps.2025.05.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。